ORIGINAL RESEARCH article
Front. Vet. Sci.
Sec. Veterinary Neurology and Neurosurgery
Volume 12 - 2025 | doi: 10.3389/fvets.2025.1685430
Current Practices for Diagnosis and Management of Canine Cognitive Dysfunction Syndrome in the United States
Provisionally accepted
- North Carolina State University, Raleigh, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
There are currently no accepted guidelines for the diagnosis and management of Canine Cognitive Dysfunction Syndrome (CCDS). The objective of this study was to describe the current diagnostic and management practices regarding CCDS by veterinarians in the United States (US). An anonymous online survey was distributed to veterinary practitioners from January to May 2025. The survey included questions regarding patient population, CCDS diagnosis and treatment and client interactions. A total of 318 survey responses were obtained from veterinarians who saw companion dogs regularly. Nearly all (97.2%) had made a diagnosis of CCDS in their career, citing patient history and clinical signs/behavioral changes as the tools they use to make a diagnosis. Most veterinarians (approximately 80%) rarely or never referred their potential CCDS cases to a veterinary specialist. When managing their CCDS patients, pharmaceuticals are most often recommended, specifically selegiline. Selegilline was also considered most effective in managing CCDS, however this view was held by only about 30% of veterinarians. Responses reflected uncertainty regarding best practices and treatment efficacies, with veterinarians citing lack of knowledge and owner-related barriers such as lack of interest or financial constraints as factors which hinder treatment recommendations. Results from this survey underscore there are still significant gaps in knowledge as to best practices for the diagnosis and management of CCDS. Clear CCDS diagnostic and management guidelines are needed to support veterinarians and address the therapeutic needs of patients.
Keywords: Canine cognitive dysfunction syndrome, Veterinarian, diagnosis, Management, Selegiline
Received: 13 Aug 2025; Accepted: 10 Oct 2025.
Copyright: © 2025 Simon, Gruen and Olby. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Natasha J Olby, njolby@ncsu.edu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.